Global Nanomedical Devices Market Size, Share, Forecast Report, 2020-2027

Nanomedical Devices Market is expected to register a CAGR of 11.9% during the forecast period of 2019 to 2025; it accounted for USD 1,872 Million in 2018.

Nanomedical devices are the modern version of the devices used for the treatment and diagnosis of diseases. Since the last decade, there has been steep growth in the development of nanomedical devices. These devices are particularly used in in vivo testing and imaging. Around 250 nanomedical products are being tested or used on humans.

Segmentation

The Global Nanomedical Devices Market has been segmented based on type, application, and end user. Based on type, the market has been segmented into implantable biosensors, implantable cardioverter-defibrillators, and others. The implantable biosensors sub-segment is expected to be the largest type market as it has an ability to provide continuous data on the levels of a target analyte. Besides, it has great potential in the diagnosis, monitoring, management, and treatment of a variety of disease conditions, which would drive the growth of the nanomedical devices market.

The market, by application, has been classified as disease treatment and diagnosis, drug release regulation, and others. Disease treatment and diagnosis segment has been further bifurcated into cancer, neurological disease, cardiovascular disease, and others. Among this, the disease treatment and diagnosis sub-segment is the fastest growing in terms of value due to rising geriatric population, increasing prevalence of various diseases such as cancer, cardiovascular disease, among others, and is predicted to achieve more revenue in the upcoming nanomedical devices market.

The market, based on end user, has been bifurcated into hospitals & clinics, research institutes and organizations, and others. Out of these, hospitals & clinics segment is the fastest-growing segment and is anticipated to hold a major market share in the market.
Key Players

The Key Players in Global Nanomedical Devices are Sanofi, Pfizer Inc, Celgene Corporation., Luminex Corporation, Taiwan Liposome Company, Ltd, Merck & Co., Inc., Nanobiotix, Starpharma Holdings Limited, CYTIMMUNE SCIENCES, INC.

Global Nanomedical Devices Market, by Type

• Implantable biosensors
• Implantable cardioverter-defibrillators
• Others

Global Nanomedical Devices Market by Product Type

• Disease Treatment and Diagnosis
  • Cancer
  • Neurological diseases
  • Cardiovascular diseases
  • Others
• Drug Release Regulation
• Others

Global Nanomedical Devices Market, by End User

• Hospital & Clinics
• Research Institutes and Organizations
• Others